 |
PDBsum entry 2bim
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
DNA binding protein
|
PDB id
|
|
|
|
2bim
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Structures of p53 cancer mutants and mechanism of rescue by second-Site suppressor mutations.
|
 |
|
Authors
|
 |
A.C.Joerger,
H.C.Ang,
D.B.Veprintsev,
C.M.Blair,
A.R.Fersht.
|
 |
|
Ref.
|
 |
J Biol Chem, 2005,
280,
16030-16037.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
We have solved the crystal structures of three oncogenic mutants of the core
domain of the human tumor suppressor p53. The mutations were introduced into a
stabilized variant. The cancer hot spot mutation R273H simply removes an
arginine involved in DNA binding without causing structural distortions in
neighboring residues. In contrast, the "structural" oncogenic
mutations H168R and R249S induce substantial structural perturbation around the
mutation site in the L2 and L3 loops, respectively. H168R is a specific
intragenic suppressor mutation for R249S. When both cancer mutations are
combined in the same molecule, Arg(168) mimics the role of Arg(249) in wild
type, and the wild type conformation is largely restored in both loops. Our
structural and biophysical data provide compelling evidence for the mechanism of
rescue of mutant p53 by intragenic suppressor mutations and reveal features by
which proteins can adapt to deleterious mutations.
|
 |
 |
 |
|
 |
|
 |
Figure 1.
FIG. 1. Structure of human p53 core domain. A, ribbon
diagram of the structure of the DNA binding (core) domain in
complex with consensus DNA (PDB code 1TSR [PDB]
, molecule B). A -sandwich provides the
basic scaffold for a loop-sheet-helix motif and two large loops
tethered by a zinc ion, which interact with the major and minor
groove of the DNA, respectively. The zinc ion is shown as a gray
sphere, and the two DNA strands are in magenta and blue. For
selected residues the side chains are shown. Among these are the
six hot spot sites Arg^175, Gly^245, Arg^248, Arg^249, Arg^273,
and Arg^282, which are most frequently mutated in human cancers
(colored in orange). The four mutation sites in the superstable
quadruple mutant M133L/V203A/N239Y/N268D (T-p53C) are
highlighted as green spheres. B, close-up view of loops L2 and
L3 in the DNA binding surface including the zinc coordination
sphere in the structure of wild type in complex with consensus
DNA (PDB code 1TSR [PDB]
, molecule B). The orientation is different from the one shown
for the whole molecule in A. The zinc ion is depicted as a gray
sphere. Specific interactions mediated via the guanidinium group
of Arg^249 are highlighted with dotted lines. These include
hydrogen bonds with backbone oxygens of residues Gly^245 and
Met^246 on the same loop and a salt bridge with Glu^171 on the
L2 loop. DNA contacts are made via Arg^248. Selected DNA
residues in the proximity of Arg^248 are shown in magenta and
cyan.
|
 |
Figure 3.
FIG. 3. Structure of T-p53C mutants H168R and R249S. A,
superposition of C atoms in the structures
of T-p53C-H168R (magenta) and T-p53C-R249S (yellow) on the
structure of T-p53C (PDB code 1UOL [PDB]
, molecule A; black). C atoms before and after
chain breaks are marked with spheres in the color of the
respective chain. B, structure of T-p53-R249S (yellow)
superimposed on the structure of p53 wild type (PDB code 1TSR
[PDB]
, molecule A; light gray). The zinc ion in both structures is
shown as a gray or yellow sphere. * denotes wild type residues.
Cys^238 in the structure of T-p53C-R249S was refined in two
alternative conformations, both contacting the zinc ion. Only
the conformation that was refined with higher occupancy (0.7) is
shown. C, stereo view of the final (2F[o] – F[c]) electron
density map at 1.9 Å resolution for mutant T-p53C-R249S
showing the peptide segment Cys^242-Met^243, the zinc ion, and
two residues that make contact with Met^243. The orientation is
the same as in B. The contour level is at 1.2 .
|
 |
|
 |
 |
|
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2005,
280,
16030-16037)
copyright 2005.
|
 |
|
Secondary reference #1
|
 |
|
Title
|
 |
Crystal structure of a superstable mutant of human p53 core domain. Insights into the mechanism of rescuing oncogenic mutations.
|
 |
|
Authors
|
 |
A.C.Joerger,
M.D.Allen,
A.R.Fersht.
|
 |
|
Ref.
|
 |
J Biol Chem, 2004,
279,
1291-1296.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
 |
 |
|
 |
|
 |
Figure 3.
FIG. 3. The structure of p53 core domain quadruple mutant
M133L/V203A/N239Y/N268D (chain A, yellow) superimposed on the
wild type structure (chain A, transparent light gray). A,
mutation site M133L; B, mutation site V203A; C, mutation site
N268D; D, mutation site N239Y. The zinc ion is shown as a gray
sphere. The large semi-transparent red spheres indicate the
location of the two cancer hot-spot sites Gly-245 and Arg-249.
|
 |
Figure 4.
FIG. 4. Polypeptide-backbone mobility in the structures of
p53 core domain quadruple mutant M133L/V203A/N239Y/N268D and
wild type. A, distribution of average isotropic B-factors for
main-chain atoms in chains A (thick solid line) and B (thin
solid line) of the quadruple mutant, and chain A (DNA-free) of
wild type (dotted line). Secondary structural elements are given
for reference; blocks represent -strands and open
circles indicate helical segments. B, relative backbone mobility
as calculated by (B-)/ [B] in chains A (thick
solid line) and B (thin solid line) of the superstable quadruple
mutant, and chain A (DNA-free) of wild type (dotted line). B-
is the deviation of the average isotropic main-chain B-factor
for a particular residue from the mean for the whole chain
(backbone atoms only), [B] the standard
deviation.
|
 |
|
 |
 |
|
The above figures are
reproduced from the cited reference
with permission from the ASBMB
|
 |
|
Secondary reference #2
|
 |
|
Title
|
 |
Crystal structure of a p53 tumor suppressor-Dna complex: understanding tumorigenic mutations.
|
 |
|
Authors
|
 |
Y.Cho,
S.Gorina,
P.D.Jeffrey,
N.P.Pavletich.
|
 |
|
Ref.
|
 |
Science, 1994,
265,
346-355.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
|
|
|
|
 |